AAAAAA
Results: 1-25/39
Authors:
HORSMANS Y
TENNSTEDT D
CORNU C
GEUBEL AP
Citation: Y. Horsmans et al., FAILURE OF CYCLOSPORINE THERAPY IN TYPE-II MIXED CRYOGLOBULINEMIA ASSOCIATED WITH HEPATITIS-C VIRUS-INFECTION, Clinical and experimental rheumatology, 16(4), 1998, pp. 514-515
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
DELZENNE N
GEUBEL AP
Citation: I. Leclercq et al., REDUCTION IN HEPATIC CYTOCHROME-P-450 IS CORRELATED TO THE DEGREE OF LIVER FAT-CONTENT IN ANIMAL-MODELS OF STEATOSIS IN THE ABSENCE OF INFLAMMATION, Journal of hepatology, 28(3), 1998, pp. 410-416
Authors:
HORSMANS Y
SEMPOUX C
DETRY R
GEUBEL AP
Citation: Y. Horsmans et al., PARACETAMOL-INDUCED LIVER TOXICITY AFTER INTRAVENOUS ADMINISTRATION, Liver, 18(4), 1998, pp. 294-295
Authors:
HAUTEKEETE ML
HORSMANS Y
VANWAEYENBERGE C
DEMANET C
HUBENS H
HENRION J
VERBIST L
BORGERS P
BRENARD R
MICHIELSEN P
VERSIECK J
ADLER M
YAO SH
RAHIER J
GEUBEL AP
Citation: Ml. Hautekeete et al., AMOXICILLIN-CLAVULANATE-INDUCED HEPATITIS IS LINKED TO THE DR-BETA-1-ASTERISK-1501 DR-BETA-5-ASTERISK-0101-DQ-BETA-1-ASTERISK-0602 HAPLOTYPE/, Hepatology, 26(4), 1997, pp. 86-86
Authors:
HORSMANS Y
SOLBREUX PM
DAENENS C
DESAGER JP
GEUBEL AP
Citation: Y. Horsmans et al., LACTULOSE IMPROVES PSYCHOMETRIC TESTING IN CIRRHOTIC-PATIENTS WITH SUBCLINICAL ENCEPHALOPATHY, Alimentary pharmacology & therapeutics, 11(1), 1997, pp. 165-170
Authors:
HORSMANS Y
LAKA A
VANBEERS BE
DESCAMPS C
GIGOT JF
GEUBEL AP
Citation: Y. Horsmans et al., HEPATOBILIARY CYSTADENOCARCINOMA WITHOUT OVARIAN STROMA AND NORMAL CA-19-9 LEVELS - UNUSUALLY PROLONGED EVOLUTION, Digestive diseases and sciences, 42(7), 1997, pp. 1406-1408
Authors:
HORSMANS Y
SALIEZ A
VANDENBERGE V
DESAGER JP
GEUBEL AP
PAUWELS S
LAMBOTTE L
Citation: Y. Horsmans et al., C-14 PROPOXYPHENE DEMETHYLATION IN THE RAT - AN EXAMPLE OF DIFFERENCES BETWEEN LIVER AND INTESTINAL DRUG-PRESYSTEMIC METABOLISM, Drug metabolism and disposition, 25(11), 1997, pp. 1257-1259
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
PAUWELS S
GEUBEL AP
Citation: I. Leclercq et al., INFLUENCE OF DIET ON LIVER VOLUME AND CYTOCHROME-P-450 (CYP) ACTIVITIES IN HUMAN NONALCOHOLIC FATTY LIVER, Hepatology, 24(4), 1996, pp. 737-737
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
DELZENNE N
GEUBEL AP
Citation: I. Leclercq et al., REDUCTION IN CYP ACTIVITIES IS CORRELATED TO THE DEGREE OF FAT LIVER CONTENT IN 2 ANIMAL-MODELS OF NUTRITIONAL STEATOSIS, Hepatology, 24(4), 1996, pp. 738-738
SERUM AND CYSTIC FLUID CA-19-9 DETERMINATIONS AS A DIAGNOSTIC HELP INLIVER CYSTS OF UNCERTAIN NATURE
Authors:
HORSMANS Y
LAKA A
GIGOT JF
GEUBEL AP
Citation: Y. Horsmans et al., SERUM AND CYSTIC FLUID CA-19-9 DETERMINATIONS AS A DIAGNOSTIC HELP INLIVER CYSTS OF UNCERTAIN NATURE, Liver, 16(4), 1996, pp. 255-257
Authors:
HORSMANS Y
GEUBEL AP
Citation: Y. Horsmans et Ap. Geubel, PRURITUS ASSOCIATED WITH CHOLESTATIC LIVER-DISEASE, Annals of internal medicine, 125(8), 1996, pp. 701-701
Authors:
HORSMANS Y
DEKONINCK X
GEUBEL AP
PAUWELS S
Citation: Y. Horsmans et al., MICROSOMAL FUNCTION IN HEPATITIS-B SURFACE-ANTIGEN HEALTHY CARRIERS -ASSESSMENT OF CYTOCHROME-P450 1A2 ACTIVITY BY THE C-14 CAFFEINE BREATH TEST, Pharmacology & toxicology, 77(4), 1995, pp. 247-249
Authors:
HORSMANS Y
SALIEZ A
VANDENBERGE V
DESAGER JP
GEUBEL AP
PAUWELS S
LAMBOTTE L
Citation: Y. Horsmans et al., LIVER AND INTESTINAL PROPOXYPHENE METABOLISMS - AN EXAMPLE OF DISCREPANCY IN DRUG PRE-SYSTEMIC BIOTRANSFORMATION IN THE RAT, Hepatology, 22(4), 1995, pp. 561-561
Authors:
PIESSEVAUX H
VANBEERS B
GIGOT JF
GEUBEL AP
HORSMANS Y
Citation: H. Piessevaux et al., MISLEADING RADIOLOGICAL PRESENTATION OF A SIMPLE HEPATIC CYST, Journal of clinical gastroenterology, 20(4), 1995, pp. 347-348
Authors:
COCHE JC
HORSMANS Y
GREER Y
GEUBEL AP
Citation: Jc. Coche et al., BUDD-CHIARI SYNDROME LIKELY RELATED TO A SLIMMING DRUG PREPARATION, Journal of hepatology, 23(5), 1995, pp. 626-627
Authors:
HORSMANS Y
GALANT C
NICHOLAS ML
LAMY M
GEUBEL AP
Citation: Y. Horsmans et al., FAILURE OF RIHAVARIN OR IMMUNOSUPPRESSIVE THERAPY TO ALTER THE COURSEOF POST-INFANTILE GIANT-CELL HEPATITIS, Journal of hepatology, 22(3), 1995, pp. 382-382
Authors:
HAUTEKEETE ML
BRENARD R
HORSMANS Y
HENRION J
VERBIST L
DERUE G
DRUEZ P
OMAR M
KOCKX M
HUBENS H
HABER I
RAHIER J
GEUBEL AP
Citation: Ml. Hautekeete et al., LIVER-INJURY RELATED TO AMOXICILLIN-CLAVULANIC ACID - INTERLOBULAR BILE-DUCT LESIONS AND EXTRAHEPATIC MANIFESTATIONS, Journal of hepatology, 22(1), 1995, pp. 71-77
Authors:
HORSMANS Y
GEUBEL AP
PAUWELS S
Citation: Y. Horsmans et al., RELIABILITY OF AMINOPYRINE BREATH TEST USING A SINGLE-BREATH COLLECTION, Digestive diseases and sciences, 40(7), 1995, pp. 1581-1581
Authors:
SCHOONBROODT D
HORSMANS Y
LAKA A
GEUBEL AP
HOANG P
Citation: D. Schoonbroodt et al., EOSINOPHILIC GASTROENTERITIS PRESENTING WITH COLITIS AND CHOLANGITIS, Digestive diseases and sciences, 40(2), 1995, pp. 308-314
Authors:
HORSMANS Y
GEUBEL AP
Citation: Y. Horsmans et Ap. Geubel, SYMPTOMATIC MYOPATHY IN HEPATITIS-C INFECTION WITHOUT INTERFERON THERAPY, Lancet, 345(8959), 1995, pp. 1236-1236
Authors:
HORSMANS Y
BRENARD R
FERRANT A
LAGNEAUX G
GEUBEL AP
Citation: Y. Horsmans et al., LONG-TERM FAVORABLE OUTCOME OF PORTAL-HYPERTENSION COMPLICATING PRIMARY SYSTEMIC AMYLOIDOSIS, Liver, 15(6), 1995, pp. 332-334
Authors:
HORSMANS Y
RAHIER J
GEUBEL AP
Citation: Y. Horsmans et al., HEPATIC-INJURY AND VITAMIN-A INGESTION, The American journal of medicine, 98(4), 1995, pp. 424-424
Authors:
VANHOOF M
WATERLOOS H
CORNU C
DEBRUYERE M
GEUBEL AP
Citation: M. Vanhoof et al., ANTI-HEPATITIS C VIRUS POSITIVITY (HCV) IN BELGIAN VOLUNTEER BLOOD-DONORS - SOURCE OF CONTAMINATION AND HCV-TESTING AMONG DONORS AND RELATED RECIPIENTS, Acta Clinica Belgica, 50(6), 1995, pp. 335-342
Authors:
KANYINDA JM
HORSMANS Y
CORNU C
GEUBEL AP
Citation: Jm. Kanyinda et al., PRECORE MUTANT CHRONIC HEPATITIS-B IN AN AUTOCHTONOUS BELGIAN POPULATION - A STUDY OF 10 PATIENTS, Acta Clinica Belgica, 50(3), 1995, pp. 144-148
Authors:
HORSMANS Y
LEBLANC B
CORNU C
FERRANT A
GEUBEL AP
Citation: Y. Horsmans et al., IMPROVEMENT OF THE COURSE OF HEPATITIS-C FOLLOWING CYTOSINE-ARABINOSIDE AS CONDITIONING TREATMENT PRIOR TO BONE-MARROW TRANSPLANTATION, HEPATOLOGY RESEARCH, 2(5), 1994, pp. 295-299